DA-5219
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DA-5219, covering 2025-08-28 to 2025-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis [Phase 3]